Jeff Cislini sold $11.9M of Revolution Medicines (RVMD)

Executed Aug 21, disclosed Aug 25, 4 days later.

Value, as filed

$11.9M

56,894 sh across 6 lots

Executed

Aug 21

the trade date, as filed

Disclosed

Aug 25

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeff Cislini SVP & General Counsel profile →

Jeff Cislini (SVP & General Counsel) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $11.9M of RVMD (56,894 sh across 6 lots, as filed), executed Aug 21.

The name

RVMD

Revolution Medicines, Inc. RVMD · Healthcare · 80 filings in 24 months ticker →

Healthcare · Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeff Cislini in RVMD

RVMDSALE Revolution Medicines, Inc. $660K
3,314 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:01 PM ET RVMDSALE Revolution Medicines, Inc. $337K
2,157 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $292K
2,958 sh across 2 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $105K
908 sh × $115.60
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $206K
2,688 sh × $76.82
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $939K
13,388 sh × $70.14
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $660K
12,000 sh × $55.00
Exec Oct 17 2025
Filed Oct 20 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $141K
2,554 sh × $55.13
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET